BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27086485)

  • 1. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
    Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma.
    Chen CL; Hsu MM
    Hum Pathol; 2000 Feb; 31(2):227-32. PubMed ID: 10685638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of second primary malignancies after nasopharyngeal carcinoma: a population-based cohort study in Taiwan.
    Lin C; Lin SW; Weng SF; Lin YS
    Head Neck; 2014 Feb; 36(2):209-14. PubMed ID: 23729214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
    J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus.
    Wang CC; Chen ML; Hsu KH; Lee SP; Chen TC; Chang YS; Tsang NM; Hong JH
    Int J Cancer; 2000 Jul; 87(2):228-31. PubMed ID: 10861479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
    Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area.
    van Velsen JS; van der Vegt B; Plaat BEC; Langendijk JA; Epskamp-Kuijpers CCHJ; van Dijk BAC; Oosting SF
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):49. PubMed ID: 38285234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology.
    Arnold M; Wildeman MA; Visser O; Karim-Kos HE; Middeldorp JM; Fles R; Bing Tan I; Coebergh JW
    Oral Oncol; 2013 Mar; 49(3):237-43. PubMed ID: 23089459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination.
    Andersson-Anvret M; Forsby N; Klein G; Henle W
    Int J Cancer; 1977 Oct; 20(4):486-94. PubMed ID: 199543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second primary malignancy after nasopharyngeal carcinoma in the United States: A population-based study.
    Chan JY; Gooi Z; Mydlarz WK; Agrawal N
    Head Neck; 2016 Apr; 38 Suppl 1():E1130-6. PubMed ID: 26314805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Yu KJ; Hsu WL; Chiang CJ; Chen TC; Liu Z; Lou PJ; Diehl S; Goldstein AM; Chen CJ; Wang CP; Hildesheim A
    Cancer; 2021 Nov; 127(22):4171-4176. PubMed ID: 34324707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal homogeneity and distinctness of the T-cell receptor β-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas.
    Chung YL; Wu ML
    Int J Cancer; 2018 Aug; 143(3):610-620. PubMed ID: 29468660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.
    Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C
    Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.
    Scélo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Tracey E; Brewster DH; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Brennan P
    Cancer Causes Control; 2007 Apr; 18(3):269-78. PubMed ID: 17237987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
    Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
    Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
    PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.